Skip To Main Content
Winnie Pong on Muck Rack

Winnie Pong

Boston
As seen in: BioCentury, MDPI, Blasting News, Multiple Sclerosis and Related Disorders

Get in touch with Winnie

Contact Winnie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Winnie Pong’s Biography

Read Full Bio →

Creating in-depth analyses on biopharma and reporting on research innovations.

Winnie Pong’s Journalist Portfolio

See all →
APPETITE FOR GFRAL: Why pharmas think GFRAL could be the next obesity target

APPETITE FOR GFRAL: Why pharmas think GFRAL could be the next obesity target

Simultaneous publications from Eli Lilly and Co., Johnson & Johnson and Novo Nordisk A/S identifying GFRAL as…

View article →
NUMERATE’S INTELLIGENCE: How Numerate's AI tackles translational questions with tiny data sets

NUMERATE’S INTELLIGENCE: How Numerate's AI tackles translational questions with tiny data sets

With three new partnerships formed since June, Numerate Inc. is picking up steam and demonstrating that indus…

View article →
EXTINGUISHING AVERSION: How activating RAC1 could extinguish aversive memories of drug withdrawal

EXTINGUISHING AVERSION: How activating RAC1 could extinguish aversive memories of drug withdrawal

Last month in the Journal of Neuroscience, a team from the Chinese Academy of Sciences showed activating RAC1…

View article →
UNCLUMPING TDP-43: Two ways TDP-43 forms aggregates in neurodegenerative disease

UNCLUMPING TDP-43: Two ways TDP-43 forms aggregates in neurodegenerative disease

Two studies published in Nature Communications have identified different features of TDP-43 that promote its …

View article →
STOPPING THE INVASION: How targeting the IRF3 pathway could prevent GBM recurrence

STOPPING THE INVASION: How targeting the IRF3 pathway could prevent GBM recurrence

A team from the Netherlands Cancer Institute (NKI) has identified a network of extracellular matrix proteins …

View article →
DISPERSING BRAIN METASTASES: Oncolytic HSV-loaded MSC could treat melanoma brain metastases

DISPERSING BRAIN METASTASES: Oncolytic HSV-loaded MSC could treat melanoma brain metastases

A Harvard team has shown that mesenchymal stem cells loaded with oncolytic HSV can treat the multi-focal brai…

View article →

Articles

Trace Element Imbalances in Acquired Hepatocerebral Degeneration and Changes after Liver Transplant

|
By Winnie Pong, Jose Silva, José Silva, Maria João Malaquias, Dina Rochate
| MDPI
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open in Who Shared Issue with article?

SARS-CoV-2 infection in patients with neuroimmunological disorders in a tertiary referral centre from the north of Portugal.

|
By João Moura, Winnie Pong, Inês Ferreira, Raquel Samões
| Multiple Sclerosis and Related Disorders Verified
1. Introduction The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic posed several challenges for patients with preceding neurological conditions. Given its impact on both the immune and nervous systems, it is particularly relevant to study coronavirus disease 2019 (COVID-19) in patients with neuroimmunological disorders. Moreover, these diseases are caused by dysregulation of immune tolerance and require either immunosuppressive or immunomodulatory therapies.
Open in Who Shared Issue with article?

Keytruda’s master class in accelerated approval

|
By Winnie Pong, Meredith Durkin Wolfe Verified
| BioCentury Verified
BioCentury Back to School Keytruda’s master class in accelerated approval Merck’s Keytruda land grab has relied on strategic use of accelerated approval pathway Merck’s Keytruda land grab in cancer has relied on the strategic use of the accelerated approval pathway. By Winnie Pong, Associate Editor, Data & Analytics, and Meredith Durkin Wolfe,
Open in Who Shared Issue with article?
See all 182 licensed articles (187 Total)